Kaloba

Pelargonium sidoides root liquid extraction preparation, the active ingredient in Kaloba, is a herbal medicine presented as a liquid oral preparation for oral use. It is traditionally used to support the body during acute respiratory tract infections such as bronchitis and the common cold. GNH USA supplies Kaloba as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Kaloba contains Pelargonium sidoides extract, which is employed in the management of upper respiratory tract conditions. - Acute bronchitis: may help relieve cough, sputum production and associated discomfort. - Common cold: supports symptom relief such as sore throat and nasal congestion. - Sinusitis: may assist in reducing sinus pressure and drainage difficulties.

Kaloba is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Altered taste: mild metallic or bitter sensation. - Gastrointestinal upset: nausea, mild abdominal discomfort. - Diarrhoea: loose stools occurring shortly after intake. - Headache: transient mild headache. - Skin irritation: mild rash or itching at the oral mucosa. - Allergic reaction: localized swelling or redness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic response requiring immediate medical attention. - Severe skin reaction: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Hepatic enzyme elevation: rare liver function abnormalities. - Severe gastrointestinal bleeding: uncommon but serious.

When considering Kaloba, observe the following precautions. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: discuss potential risks with a medical provider. - Children: use only under pediatric guidance. - Concomitant illness: inform the prescriber of any chronic conditions. - Drug interactions: review all current medications with a pharmacist. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Kaloba may interact with certain medicines; monitor accordingly.

Major Interactions (Avoid): - Warfarin: increased risk of bleeding. - Immunosuppressants: potential reduction of therapeutic effect.

Moderate Interactions (Monitor Closely): - Antibiotics (e.g., macrolides): possible alteration of antimicrobial activity. - Antihistamines: may enhance sedative effects. - Oral contraceptives: possible reduction in contraceptive efficacy.